QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Sertraline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 200 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Sertraline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 20 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Sertraline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 200 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Sertraline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 80 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Serum Amyloid A (SAA) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.0696 – 218 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
SHBG (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 2 – 180 nmol/L |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Immulite |
| Site: | QPS-NL |
| CLIA: | |
| Therapy Area: | |
| Classification: | Biochemical Biomarkers |
Sildenafil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Sodium Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Vasodilator |
| Classification: | Drug Assays |
SildenafilN-Desmethyl Sildenafil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 1,500 ng/mL 5 – 700 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Vasodilator |
| Classification: | Drug Assays |
SildenafilN-Desmethyl Sildenafil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Vasodilator |
| Classification: | Drug Assays |
Silver (Matrix: Formulation)
| Matrix: | Formulation |
| Assay Range: | 10.0 – 1,000 ng/mL |
| Sample Volume: | 125 µL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | 2 – 8 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
Silver (Matrix: Solid Samples)
| Matrix: | Solid Samples |
| Assay Range: | 10.0 – 1,000 ng/mL |
| Sample Volume: | 250 mg |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | 2 – 8 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
Simvastatin
Simvastatin Acid (Matrix: Human Plasma)
Simvastatin Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 10 ng/mL 0.02 – 4 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.250 – 75 ng/mL 0.2 – 50 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.250 – 125 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Simvastatin
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
Simvastatin Hydroxy Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 25 ng/mL 0.02 – 10 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Sirolimus (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | 0.2 – 100 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Sirolimus (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | 0.5 – 60 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
SirolimusTemsirolimus (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | 0.1 – 50 ng/mL 0.25 – 125 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Immunosuppressant |
| Classification: | Drug Assays |
Sitagliptin Metformin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 3 – 1500 ng/mL 10 – 5000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
SLCO1B1 (*1B, *5) (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | TaqMan |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Solifenacin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.3 – 50 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Bladder Relaxant |
| Classification: | Drug Assays |
Soluble GP130 (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.250 – 1600 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Sorafenib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10.0 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Sotalol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 90.0 – 5,000 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | HPLC-UV |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
ß2-microglobulin (B2M) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.200 – 2.50 mg/L |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Nephelometry |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
